Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity
Without any planning target volume expansion, HA efficiently delivers high-quality plans with sharp dose fall-off for a wide variety of BITs. Early clinical outcomes and toxicity are consistent with historical controls.
Authors
- Whitney S. Hotsinpiller
- Evan Thomas (ORCID: https://orcid.org/0000-0003-2172-6049)
- Kristen Owen Riley (ORCID: https://orcid.org/0000-0001-5895-6855)
- Drexell H. Boggs (ORCID: https://orcid.org/0000-0003-1046-1671)
- Richard A. Popple (ORCID: https://orcid.org/0000-0003-1252-738X)
- James M. Markert (ORCID: https://orcid.org/0000-0001-7457-7329)
- Barton L. Guthrie (ORCID: https://orcid.org/0000-0003-0428-3047)
- Christopher D. Willey (ORCID: https://orcid.org/0000-0001-9953-0279)
- Markus Bredel (ORCID: https://orcid.org/0000-0002-7828-0984)
- John B. Fiveash (ORCID: https://orcid.org/0000-0002-1129-2884)
- Ian Tsekouras
Institutions
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Renaissance Computing Institute (US)
Publication Details
- Journal
- Journal of Neuro-Oncology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1007/s11060-025-05291-8
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00